MA54510A - Procédé de séchage par pulvérisation de peptide glp-1 - Google Patents

Procédé de séchage par pulvérisation de peptide glp-1

Info

Publication number: MA54510A
Authority: MA; Morocco
Prior art keywords: glp; drying process; spray drying; peptide spray; peptide
Prior art date: 2018-12-21

Application number

MA054510A

Other languages

English (en)

Inventor

Pall Thor Ingvarsson

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-12-21

Filing date

2019-12-20

Publication date

2022-03-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=65013488&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA54510(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2019-12-20 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

2022-03-30 Publication of MA54510A publication Critical patent/MA54510A/fr

Links

102100025101 GATA-type zinc finger protein 1 Human genes 0.000 title 1
101710198884 GATA-type zinc finger protein 1 Proteins 0.000 title 1
DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 title 1
238000000034 method Methods 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1
238000001694 spray drying Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/184—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D1/00—Evaporating
- B01D1/14—Evaporating with heated gases or vapours or liquids in contact with the liquid
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D1/00—Evaporating
- B01D1/16—Evaporating by spraying
- B01D1/18—Evaporating by spraying to obtain dry solids
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D1/00—Evaporating
- B01D1/16—Evaporating by spraying
- B01D1/20—Sprayers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Zoology (AREA)
Epidemiology (AREA)
Polymers & Plastics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
General Chemical & Material Sciences (AREA)
Hematology (AREA)
Obesity (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Food Science & Technology (AREA)
Animal Husbandry (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Peptides Or Proteins (AREA)

MA054510A 2018-12-21 2019-12-20 Procédé de séchage par pulvérisation de peptide glp-1 MA54510A (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP18215348		2018-12-21

Publications (1)

Publication Number	Publication Date
MA54510A true MA54510A (fr)	2022-03-30

Family

ID=65013488

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA054510A MA54510A (fr)	2018-12-21	2019-12-20	Procédé de séchage par pulvérisation de peptide glp-1

Country Status (7)

Country	Link
US (1)	US11617965B2 (fr)
EP (1)	EP3897582B1 (fr)
JP (1)	JP7410952B2 (fr)
CN (1)	CN113194929B (fr)
ES (1)	ES2994462T3 (fr)
MA (1)	MA54510A (fr)
WO (1)	WO2020127950A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MA54510A (fr)	2018-12-21	2022-03-30	Novo Nordisk As	Procédé de séchage par pulvérisation de peptide glp-1
CN113631251B (zh) *	2019-03-15	2025-04-25	诺和诺德股份有限公司	Glp-1肽的喷雾干燥工艺
CN114191541A (zh) *	2020-09-02	2022-03-18	齐鲁制药有限公司	喷雾冷冻干燥法制备索玛鲁肽微粒
US20240115497A1 (en) *	2021-02-05	2024-04-11	Zhejiang Cuize Pharmaceutical Technology Co., Ltd.	Inhalable pharmaceutical powder formulation and preparation method therefor
KR102849380B1 (ko) *	2022-12-16	2025-08-21	포스코홀딩스 주식회사	황화 리튬의 제조 방법
WO2025133729A1 (fr)	2023-12-18	2025-06-26	Assia Chemical Industries Ltd.	Procédé de préparation de peptides glp-1 et de peptides glp-1/gip doubles ayant une taille de particule contrôlée

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPO637197A0 (en)	1997-04-23	1997-05-15	F.H. Faulding & Co. Limited	Taste-masked pharmaceutical compositions
US6223455B1 (en)	1999-05-03	2001-05-01	Acusphere, Inc.	Spray drying apparatus and methods of use
WO2001093837A2 (fr)	2000-06-08	2001-12-13	Eli Lilly And Company	Poudre proteinique administree par voie pulmonaire
AU2002308706A1 (en) *	2001-06-01	2002-12-16	Eli Lilly And Company	Glp-1 formulations with protracted time action
TWI372629B (en)	2005-03-18	2012-09-21	Novo Nordisk As	Acylated glp-1 compounds
ES2402172T3 (es)	2007-04-23	2013-04-29	Intarcia Therapeutics, Inc	Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
ES2563038T3 (es)	2007-04-30	2016-03-10	Novo Nordisk A/S	Método para secar una composición proteica, una composición proteica seca y una composición farmacéutica que comprende la proteína seca
US20100183876A1 (en) *	2008-12-23	2010-07-22	Hell Andre	Process for the Preparation of a Peptide Powder Form
US20120208755A1 (en)	2011-02-16	2012-08-16	Intarcia Therapeutics, Inc.	Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US20130172271A1 (en) *	2012-01-04	2013-07-04	Cynthia Fragale	Pharmaceutical Spray Drying
EP2827885B1 (fr) *	2012-03-22	2018-08-15	Novo Nordisk A/S	Compositions de peptides glp-1 et leur préparation
US9993430B2 (en) *	2012-06-20	2018-06-12	Novo Nordisk A/S	Tablet formulation comprising semaglutide and a delivery agent
KR102246914B1 (ko) *	2013-03-15	2021-04-30	맨카인드 코포레이션	미세결정성 디케토피페라진 조성물 및 방법
CN105246459A (zh)	2013-05-30	2016-01-13	诺和诺德股份有限公司	治疗糖尿病的新的口服药用组合物
PT107567B (pt)	2014-03-31	2019-02-13	Hovione Farm S A	Secador por atomização com atomizador múltiplo, método para o aumento de escala de pós para inalação secos por dispositivo de atomização múltiplo e uso de vários atomizadores num secador por atomização
CN106924750B (zh)	2015-12-31	2021-03-23	深圳翰宇药业股份有限公司	一种索马鲁肽口服微粒制剂及其制备方法
KR20180135012A (ko)	2016-04-28	2018-12-19	노보 노르디스크 에이/에스	심혈관 병태에서의 세마글루타이드
EP3526533A1 (fr) *	2016-10-13	2019-08-21	Capsugel Belgium NV	Procédé de fabrication de compositions séchées par pulvérisation et appareil de séchage par pulvérisation
CN108745218A (zh)	2018-06-26	2018-11-06	苏州大学	一种制备多肽微球的装置及方法
MA54510A (fr)	2018-12-21	2022-03-30	Novo Nordisk As	Procédé de séchage par pulvérisation de peptide glp-1

2019
- 2019-12-20 MA MA054510A patent/MA54510A/fr unknown
- 2019-12-20 EP EP19828757.5A patent/EP3897582B1/fr active Active
- 2019-12-20 ES ES19828757T patent/ES2994462T3/es active Active
- 2019-12-20 WO PCT/EP2019/086645 patent/WO2020127950A1/fr not_active Ceased
- 2019-12-20 JP JP2021535869A patent/JP7410952B2/ja active Active
- 2019-12-20 CN CN201980084815.3A patent/CN113194929B/zh active Active
- 2019-12-20 US US17/415,623 patent/US11617965B2/en active Active

Also Published As

Publication number	Publication date
WO2020127950A1 (fr)	2020-06-25
EP3897582C0 (fr)	2024-09-11
JP2022514893A (ja)	2022-02-16
CN113194929A (zh)	2021-07-30
US20220088500A1 (en)	2022-03-24
EP3897582A1 (fr)	2021-10-27
ES2994462T3 (en)	2025-01-24
US11617965B2 (en)	2023-04-04
EP3897582B1 (fr)	2024-09-11
JP7410952B2 (ja)	2024-01-10
CN113194929B (zh)	2022-12-09

Publication	Publication Date	Title
MA54510A (fr)	2022-03-30	Procédé de séchage par pulvérisation de peptide glp-1
EP3874215C0 (fr)	2024-01-17	Système de séchage par pulvérisation électrostatique
EP3778621A4 (fr)	2021-06-30	Procédé de synthèse peptidique
DK4155640T3 (da)	2024-07-15	Sprøjtetørrer
IL286119A (en)	2021-10-31	Aerosol provision system
HUE057083T2 (hu)	2022-04-28	C-típusú nátriuretikus peptid változatainak alkalmazása oszteoartritisz kezelésére
EP3954468C0 (fr)	2024-05-15	Pistolet de pulvérisation
EP4063019A4 (fr)	2022-12-14	Pistolet de pulvérisation
EP3610003A4 (fr)	2021-01-06	Procédé de production de virus recombinant
EP3766984A4 (fr)	2021-05-12	Procédé de détermination
EP3749064A4 (fr)	2021-01-20	Machine de traitement au plasma
EP3890891C0 (fr)	2024-08-07	Pistolet pulvérisateur de peinture
EP4265992C0 (fr)	2025-10-22	Ensemble buse de séchage par pulvérisation électrostatique
EP3953503C0 (fr)	2025-09-24	Procédé de polissage électrolytique
EP3494806C0 (fr)	2025-08-06	Lacto-n-fucopentaose séché par pulvérisation
EP3979796C0 (fr)	2024-10-09	Dispositif d'application de pulvérisation
EP4382149C0 (fr)	2025-11-19	Pulvérisation nasale bi-dose
EP4081687A4 (fr)	2023-01-18	Procédé de construction
JP1711552S (ja)	2022-04-01	スプレーガン
IL286425A (en)	2021-10-31	Aerosol provision system
EP3494804C0 (fr)	2025-08-13	3-fucosyllactose séché en pulvérisation
PL3539929T3 (pl)	2025-04-07	Układ do suszenia rozpyłowego
EP3528318A4 (fr)	2019-10-30	Procédé de séchage d'électrode
EP4408590A4 (fr)	2025-08-27	Pistolet de pulvérisation
EP3820169A4 (fr)	2021-12-22	Procédé de configuration de paramètres